Company Overview of Shire Human Genetic Therapies, Inc.
Key Executives for Shire Human Genetic Therapies, Inc.
|Søren Tulstrup M.Sc||No Relationships||Senior Vice President and Franchise Lead of Mucopolysaccharides||51|
|Marcio Voloch Ph.D.||No Relationships||Vice President of Process Development||--|
|Daniella M. Lutz||No Relationships||Corporate Communications Manager||--|
Shire Human Genetic Therapies, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Jonathan S. Leff M.B.A||178 Relationships||Deerfield Management Company, L.P.||47|
|Rodman W. Moorhead III||92 Relationships||Scientific Learning Corp.||72|
Shire Human Genetic Therapies, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Nominating Committee M.B.A||Jonathan S. Leff||178 Relationships||1 Executives|
|Corporate Governance Committee M.B.A||Jonathan S. Leff||178 Relationships||1 Executives|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.